PROKIDNEY CORP. - Class A Common Stock (PROK) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2025 to Q4 2025

Type / Class
Equity / Class A Common Stock
Symbol
PROK on Nasdaq
Shares outstanding
141,999,700
Price per share
$2.13
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
41,944,849
Total reported value
$93,956,490
% of total 13F portfolios
0%
Share change
+8,493,675
Value change
+$18,974,610
Number of holders
61
Price from insider filings
$2.13
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of PROKIDNEY CORP. - Class A Common Stock (PROK) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MORGAN STANLEY 6% $19,510,759 8,519,982 Morgan Stanley 31 Dec 2025

As of 31 Dec 2025, 61 institutional investors reported holding 41,944,849 shares of PROKIDNEY CORP. - Class A Common Stock (PROK). This represents 30% of the company’s total 141,999,700 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of PROKIDNEY CORP. - Class A Common Stock (PROK) together control 29% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
SUVRETTA CAPITAL MANAGEMENT, LLC 8.7% 12,341,266 0% 0.69% $27,644,436
MORGAN STANLEY 6.2% 8,817,001 +31% 0% $19,750,082
Bleichroeder LP 1.4% 2,000,000 0% 0.79% $4,480,000
Artia Global Partners LP 1.3% 1,838,411 0.66% $4,118,041
MILLENNIUM MANAGEMENT LLC 1.3% 1,834,536 -6.2% 0% $4,109,361
VANGUARD GROUP INC 1.2% 1,648,229 +5.4% 0% $3,692,033
Hennion & Walsh Asset Management, Inc. 1.1% 1,503,886 +63% 0.12% $3,368,705
BlackRock, Inc. 0.99% 1,404,167 +9.9% 0% $3,145,334
GEODE CAPITAL MANAGEMENT, LLC 0.84% 1,197,530 +9.2% 0% $2,683,540
RENAISSANCE TECHNOLOGIES LLC 0.63% 895,705 +579% 0% $2,006,379
BANK OF AMERICA CORP /DE/ 0.5% 706,144 +6.9% 0% $1,581,763
GOLDMAN SACHS GROUP INC 0.48% 681,161 +314% 0% $1,525,801
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.44% 623,110 -4.6% 0% $1,395,766
MARSHALL WACE, LLP 0.43% 612,485 +654% 0% $1,371,967
Woodline Partners LP 0.35% 500,000 0% $1,120,000
JANE STREET GROUP, LLC 0.35% 493,849 +616% 0% $1,106,222
STATE STREET CORP 0.34% 480,345 +1.1% 0% $1,075,973
TWO SIGMA INVESTMENTS, LP 0.33% 465,509 +369% 0% $1,042,740
MYDA Advisors LLC 0.31% 440,000 -2.2% 0.28% $985,600
UBS Group AG 0.29% 416,539 -18% 0% $933,047
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.28% 398,880 +56% 0% $893,491
CITADEL ADVISORS LLC 0.26% 371,797 +7.8% 0% $832,825
Squarepoint Ops LLC 0.25% 351,421 +2% 0% $787,183
Amundi 0.19% 272,242 0% $609,822
NORTHERN TRUST CORP 0.17% 241,580 +27% 0% $541,139

Institutional Holders of PROKIDNEY CORP. - Class A Common Stock (PROK) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 41,944,849 $93,956,490 +$18,974,610 $2.24 61
2025 Q3 33,452,097 $80,954,450 +$79,786,213 $2.42 55
2025 Q2 527,620 $311,428 +$311,428 $0.59 5